Cognition Disorders Completed Phase 4 Trials for Donepezil (DB00843)

Also known as: Cognition Disorder

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00042172Treatment for Early Memory LossTreatment
NCT00267163Brain Imaging and Mental Disorders of Aging InterventionPrevention